Category:
Miscellaneous
BC Cancer Agency
Site Home - British Columbia Cancer Agency
|
|
Category:
Miscellaneous
PubMed
Cancer Site
|
|
Category:
Miscellaneous
Susan Love M.D. The Website For Women
Site Home Page
|
|
Category:
Definition & Diagnosis
Is It Really Duct Carcinoma In Situ?
To the question "Is axillary node staging required in patients with duct carcinoma in situ (DCIS) of the breast?" there are two possible responses: a short answer and a long one.
|
|
Category:
Diet & Exercise
Annals of Surgical Oconlolgy
Cancer Site
|
|
Category:
Definition & Diagnosis
The National Coalition For Cancer Survivorship
Breast cancer is a common malignancy, with almost 200,000 new cases diagnosed in the United States each year. The disease occurs most frequently in women and rarely, in men. The breasts are glands that produce and release milk in women in association with pregnancy. Breast cancer develops from cells in the breast.
|
|
Category:
Medical Studies
Radiation Therapy Important After DCIS Surgery
Mammography screening detects many breast cancers in their earliest stage, known as ductal carcinoma in situ (DCIS). This kind of cancer involves an uncontrolled growth of breast cells that stay on the inside of the milk duct. The cells have not started to break through the wall of the duct into the normal surrounding breast tissue. You might have heard other names for this kind of cancer, including non-invasive, pre-cancer, and Stage 0 (zero).
|
|
Category:
Medical Studies
Radiation Therapy
Radiation therapy is offered to breast cancer patients to rid the body of any microscopic cancer cells that may remain near the area where the cancer was originally found. The usual course of therapy includes daily treatments five days a week for five to seven weeks. Each session generally lasts an hour or less.
|
|
Category:
Medical Studies
Adjuvant radiation therapy for DCIS
Omission of breast radiation after breast conservation surgery is associated with higher incidence of recurrence rate. This is true for both ductal carcinoma in situ and invasive breast cancer.
|
|
Category:
Medical Studies
What's New In Breast Cancer Research?
MedicineWorld.Org brings daily breast cancer news from various sources to keep you updated on the latest events in the world of breast cancer. Medicineworld cancer news service is the most comprehensive cancer news service on the internet. We keep an archive of previous few days of news on this site
|
|
Category:
Miscellaneous
The Breast Cancer Forum
Questions in the breast cancer forum are being answered by
medical professionals from the Cleveland Clinic's Breast Center
|
|
Category:
Medical Studies
Breast Papers
Dozens of summaries. Some Titles:
Sentinel node localisation in patients with breast cancer.
Detection of residual disease following breast conserving surgery
Radiotherapy in breast-conserving treatment for ductal carcinoma in-situ
Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast cancer.
|
|
Category:
Medical Studies
Small Breast Cancers Benefit from Radiation After Lumpectomy
For years, doctors have questioned whether certain women need radiation treatment after having a lumpectomy. These are women with very small breast cancers (one centimeter or less) and negative lymph nodes (no cancer cells found in the nodes).
|
|
Category:
Definition & Diagnosis
Margins of Resection
Negative and positive "margins" or "margins of resection" (the distance between the tumor and the edge of the tissue)
|
|
Category:
Miscellaneous
National Center for Complimentary and Alternative Medicine
Site Home
NCCAM is dedicated to exploring complementary and alternative healing practices in the context of rigorous science, training complementary and alternative medicine (CAM) researchers, and disseminating authoritative information to the public and professionals.
|
|
Category:
Medical Studies
Can Women Who Have Had Breast Cancer Use Urogenital Estrogen Replacement?
What are the concerns in using long-term urogenital estrogen replacement in women who have had breast cancer? I often treat atrophic vaginitis and urethritis with estrogen cream. The women with a history of breast cancer are hesitant to use estrogen.
|
|
Category:
Medical Studies
Cancer and Sexuality
This patient summary on the sexual side effects from cancer and cancer treatment is adapted from the summary written for health professionals by cancer experts. This and other credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials, is available from the National Cancer Institute. Better treatment of many cancers has resulted in more patients experiencing longer periods of disease-free survival. In addition, the side effects associated with cancer and cancer treatments have also become more prevalent.
|
|
Category:
Medical Studies
The diagnosis and management of pre-invasive breast disease
The treatment of ductal carcinoma in situ (DCIS) involves adequate surgical excision with adjuvant
radiotherapy where appropriate. An inadequate excision margin and young age are independent risk
factors for local recurrence
|
|
Category:
Medical Studies
HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: fr
Recent clinical data have suggested that the efficacy of tamoxifen in reducing the risk of local recurrence following lumpectomy and radiation therapy in patients with ductal carcinoma in situ (DCIS) is limited to patients with estrogen receptor (ER)-positive lesions. However, it is currently not known if HER2 protein overexpression might be associated with reduced tamoxifen benefit in patients with ER-positive DCIS, as has been suggested in patients with ER-positive invasive breast cancer and in preclinical models
|
|
Category:
Medical Studies
Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction
The natural history of DCIS, a disease with a breast cancer-specific mortality rate of only 1% after mastectomy, suggests that DCIS is exactly what we think it is: a non-obligate precursor of invasive breast cancer with little or no metastatic potential while it is in the in situ phase. Why pursue immunohistochemically detected cytokeratin positive material in patients with such minimal disease?
|
|